Sedation

Sedana Medical Enters China - Signs With Chinese Distributor

Retrieved on: 
Monday, June 3, 2019
Anesthesia, Sedation, Intensive care medicine, Medicine

STOCKHOLM, June 3, 2019 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a 10-year exclusive distribution agreement with the Chinese distributor Kyuan Xinhai Medical, a subsidiary of partly state-owned Shanghai Pharma, the second largest life science company in China.

Key Points: 
  • STOCKHOLM, June 3, 2019 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a 10-year exclusive distribution agreement with the Chinese distributor Kyuan Xinhai Medical, a subsidiary of partly state-owned Shanghai Pharma, the second largest life science company in China.
  • Sedana Medical estimates that the Chinese market potential for sedation in intensive care is five to six million ventilation days annually.
  • "We are happy to take on this commitment with Sedana Medical as we see how beneficial the therapy can be for patients in China.
  • Sedana Medical AB (publ) has developed and sells the medical device AnaConDa, for the administration of volatile anaesthetics to mechanically ventilated patients.

U.S. Navy Veteran Turned Physician Opens Resurgence Ketamine Clinic in Response to Growing Mental Health and Opioid Crisis

Retrieved on: 
Tuesday, April 16, 2019
Surgery, Health, Hospitals, Mental health, Pharmaceutical, Research, Science, General Health, Drugs, Psychoactive drugs, Neurochemistry, General anesthetics, Chloroarenes, NMDA receptor antagonists, Nicotinic antagonists, Sedatives, Ketamine, Sedation, Pain, Treatment-resistant depression

Now, in the Southern Colorado region, those who suffer from mood disorders, chronic pain, treatment-resistant depression, addiction and post traumatic stress disorder can find relief at the Resurgence Ketamine Clinic.

Key Points: 
  • Now, in the Southern Colorado region, those who suffer from mood disorders, chronic pain, treatment-resistant depression, addiction and post traumatic stress disorder can find relief at the Resurgence Ketamine Clinic.
  • The founder of Resurgence Ketamine Clinic, Dr. Christian Hodach, has used ketamine throughout his career as an anesthesiologist for sedation of patients undergoing surgery.
  • At Resurgence Ketamine Clinic we offer customized, state-of-the-art treatments, which can havedouble the efficacyof standard medications, providing relief in days.
  • Please visit www.resurgenceketamine.com for more information about our company as well as more information and research on ketamine infusion treatment.

Sedation - Pipeline Review, H1 2019 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 16, 2019
Health, Pharmaceutical, Anesthesia, Sedation

Sedation - Pipeline Review, H1 2019 provides comprehensive information on the therapeutics under development for Sedation (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Key Points: 
  • Sedation - Pipeline Review, H1 2019 provides comprehensive information on the therapeutics under development for Sedation (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
  • The Sedation (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Sedation and features dormant and discontinued projects.
  • The pipeline guide reviews pipeline therapeutics for Sedation (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Formulate corrective measures for pipeline projects by understanding Sedation (Central Nervous System) pipeline depth and focus of Indication therapeutics.

Regular Cannabis Users Require Up to 220% Higher Dosage for Sedation in Medical Procedures

Retrieved on: 
Monday, April 15, 2019
Medicine, Health, Medical specialties, Cannabis smoking, Herbalism, Medicinal plants, Anesthesia, Cannabis, Effects of cannabis, Sedation, Medical cannabis, Legality of cannabis

Researchers in Colorado examined medical records of 250 patients who received endoscopic procedures after 2012, when the state legalized recreational cannabis.

Key Points: 
  • Researchers in Colorado examined medical records of 250 patients who received endoscopic procedures after 2012, when the state legalized recreational cannabis.
  • "Cannabis has some metabolic effects we don't understand and patients need to know that their cannabis use might make other medications less effective.
  • He also says that colleagues in anesthesiology have noted patients requiring much higher dosages for general anesthesia and higher rates of post-op seizures.
  • Dr. Twardowski's team is developing a follow-up study on differences in requirements for sedation and anesthesia as well as post-procedure pain management for regular cannabis users versus non users.

Reimagine Well Launches "Experiential Education" Program to Reduce Need for Pediatric Sedation

Retrieved on: 
Tuesday, April 2, 2019
Anesthesia, Sedation, Virtual reality headset

Research is beginning to show a correlation between frequent pediatric sedation and long-term developmental problems for young patients,"said Dr. Leonard Sender, Medical Director of Children's Hospital of Orange County and Co-Founder of Reimagine Well .

Key Points: 
  • Research is beginning to show a correlation between frequent pediatric sedation and long-term developmental problems for young patients,"said Dr. Leonard Sender, Medical Director of Children's Hospital of Orange County and Co-Founder of Reimagine Well .
  • Clinicians can coach, guide, and acclimate the patient to procedures ahead of time, both on computer screens and VR headsets.
  • "Our prior proof of concept pilot showed that 100% of children under the age of 5 received sedation to complete their radiation therapy.
  • The sedation reduction program and Reimagine Well's additional "Community VR" experiences can be previewed at the Association of Child Life Professionals (ACLP) Conference, April 11th-14th in Chicago, Illinois.

Positive Interim Analysis in Pivotal IsoConDa Phase III Study

Retrieved on: 
Friday, March 8, 2019
Anesthesia, Medical specialties, Chemistry, Drugs, Sedation, Inhalation sedation, Isoflurane

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced the results of the interim analysis for the company's pivotal phase III study aimed at getting the candidate drug IsoConDa (isoflurane) approved for inhalation sedation in intensive care in Europe.

Key Points: 
  • Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced the results of the interim analysis for the company's pivotal phase III study aimed at getting the candidate drug IsoConDa (isoflurane) approved for inhalation sedation in intensive care in Europe.
  • The interim analysis shows a low standard deviation in the primary variable, the proportion of time with adequate sedation, i.e.
  • The interim analysis is a milestone and we can now continue to work with the study at a rapid rate.
  • In 2017, Sedana Medical initiated a pivotal clinical phase III study aimed at getting IsoConDa (isoflurane) approved for inhalation sedation in intensive care in Europe.

Positive Interim Analysis in Pivotal IsoConDa Phase III Study

Retrieved on: 
Friday, March 8, 2019
Anesthesia, Medical specialties, Chemistry, Drugs, Sedation, Inhalation sedation, Isoflurane

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced the results of the interim analysis for the company's pivotal phase III study aimed at getting the candidate drug IsoConDa (isoflurane) approved for inhalation sedation in intensive care in Europe.

Key Points: 
  • Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced the results of the interim analysis for the company's pivotal phase III study aimed at getting the candidate drug IsoConDa (isoflurane) approved for inhalation sedation in intensive care in Europe.
  • The interim analysis shows a low standard deviation in the primary variable, the proportion of time with adequate sedation, i.e.
  • The interim analysis is a milestone and we can now continue to work with the study at a rapid rate.
  • In 2017, Sedana Medical initiated a pivotal clinical phase III study aimed at getting IsoConDa (isoflurane) approved for inhalation sedation in intensive care in Europe.

Savannah Dental Solutions Offers a Free Sedation Dentistry Consultation in February 2019

Retrieved on: 
Tuesday, February 12, 2019
Psychoactive drugs, Neurochemistry, Medical specialties, Anesthesia, Dentistry, Sedation, Outline of dentistry and oral health, Nitrous oxide, Dentist

In February 2019, Savannah Dental Solutions is pleased to offer a complimentary sedation dentistry consultation to anyone who feels that this solution might help.

Key Points: 
  • In February 2019, Savannah Dental Solutions is pleased to offer a complimentary sedation dentistry consultation to anyone who feels that this solution might help.
  • Dental sedation falls into three basic types:
    The mildest form of dental sedation is nitrous oxide, sometimes known as laughing gas.
  • Those who are interested in learning more are encouraged to call (912) 354-1366 and mention this offer to schedule a free sedation dentistry consultation.
  • Savannah Dental Solutions is located at 9A Medical Arts Center, Savannah, GA 31405.

Premier Inc. Announces Expanded Effort to Supply Shortage Generic Drugs

Retrieved on: 
Monday, January 14, 2019
Practice Management, Health, Hospitals, Pharmaceutical, Medicine, Health, Chemotherapy, Occupational safety and health, Oncology, Sedation, Pharmacy, Drug

ProvideGx has already partnered with five high-quality generic manufacturers to address a targeted pipeline of 60 crucial drugs, and expects to begin marketing additional shortage products next month, pending approval by the U.S. Food and Drug Administration.

Key Points: 
  • ProvideGx has already partnered with five high-quality generic manufacturers to address a targeted pipeline of 60 crucial drugs, and expects to begin marketing additional shortage products next month, pending approval by the U.S. Food and Drug Administration.
  • According to the University of Utah Drug Information Service, 224 vital medications are in current shortage nationwide, including antimicrobials, cardiovascular drugs, sedation medications, electrolytes, nutritional supplements and chemotherapy drugs.
  • ProvideGx is guided by 31 Premier member health systems and the companys National Pharmacy Committee, representing more than 1,000 hospitals across the nation.
  • With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.

Kaplan Sinus Relief offers Balloon Sinuplasty with IV Sedation: All the Relief, None of the Anxiety

Retrieved on: 
Wednesday, January 9, 2019
Balloon sinuplasty, Sedation, Sinus

Dr. Michael Kaplan of Houston's Kaplan Sinus Relief said he decided to make IV sedation an option for his patients because he wants it to be easier for them to find relief from sinus problems.

Key Points: 
  • Dr. Michael Kaplan of Houston's Kaplan Sinus Relief said he decided to make IV sedation an option for his patients because he wants it to be easier for them to find relief from sinus problems.
  • Balloon sinuplasty is a minimally invasive, in-office sinus surgery that can be completed in less than 20 minutes.
  • To learn more about the balloon sinuplasty procedure and IV sedation, contact Kaplan Sinus Relief at 713-776-1818 or request your appointment online today.
  • Watch balloon sinuplasty testimonials from Kaplan Sinus Relief patients on their YouTube page.